These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14979908)

  • 21. Beta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs.
    Gebeshuber CA; Sladecek S; Grunert S
    Cells Tissues Organs; 2007; 185(1-3):51-60. PubMed ID: 17587808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
    Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
    Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt signalling and the mechanistic basis of tumour development.
    Ilyas M
    J Pathol; 2005 Jan; 205(2):130-44. PubMed ID: 15641015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
    Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
    Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidermal growth factor].
    Inobe M; Takeda S
    Tanpakushitsu Kakusan Koso; 2000 Sep; 45(13 Suppl):2116-22. PubMed ID: 11021212
    [No Abstract]   [Full Text] [Related]  

  • 26. ADAM metalloproteases and EGFR signalling.
    Gee JM; Knowlden JM
    Breast Cancer Res; 2003; 5(5):223-4. PubMed ID: 12927027
    [No Abstract]   [Full Text] [Related]  

  • 27. Growth factor signalling in endocrine and anti-growth factor resistant breast cancer.
    Nicholson RI; Hutcheson IR; Jones HE; Hiscox SE; Giles M; Taylor KM; Gee JM
    Rev Endocr Metab Disord; 2007 Sep; 8(3):241-53. PubMed ID: 17486454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of investigating epidermal growth factor receptors in breast cancer].
    Gershteĭn ES; Bassalyk LS; Letiagin VP
    Vopr Onkol; 1994; 40(7-12):266-75. PubMed ID: 7610619
    [No Abstract]   [Full Text] [Related]  

  • 29. Wnt signaling and orthopedic diseases.
    Ishikawa Y
    Am J Pathol; 2005 Jul; 167(1):1-3. PubMed ID: 15972946
    [No Abstract]   [Full Text] [Related]  

  • 30. Environmental causes and molecular biology of breast cancer: future research directions.
    Jahnke GD; Barrett JC
    Prog Clin Biol Res; 1996; 394():455-69. PubMed ID: 8778810
    [No Abstract]   [Full Text] [Related]  

  • 31. What's new in the importance of receptors in pathology?
    Dietel M; Kostrouch Z; Courtoy PJ; Boonstra J; Toth J
    Pathol Res Pract; 1988 Dec; 184(1):116-27. PubMed ID: 2852799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decoding epithelial signals: critical role for the epidermal growth factor receptor in controlling intestinal transport function.
    McCole DF; Barrett KE
    Acta Physiol (Oxf); 2009 Jan; 195(1):149-59. PubMed ID: 18983445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What DKKtates where to metastasize.
    Zheng W; Pollard JW
    Nat Cell Biol; 2017 Sep; 19(10):1146-1148. PubMed ID: 28960204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SnapShot: breast cancer.
    Polyak K; Metzger Filho O
    Cancer Cell; 2012 Oct; 22(4):562-562.e1. PubMed ID: 23079664
    [No Abstract]   [Full Text] [Related]  

  • 35. Cancer: escape route from a "doomed" host?
    Moore A
    Bioessays; 2012 Jan; 34(1):2. PubMed ID: 22170469
    [No Abstract]   [Full Text] [Related]  

  • 36. Growth factor signalling pathways in cancer progression: complexities and therapeutic opportunities. Proceedings of the 2nd Tenovus/AstraZeneca Workshop. April 20-21, 2006. Cardiff, United Kingdom.
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S1-135. PubMed ID: 17259551
    [No Abstract]   [Full Text] [Related]  

  • 37. Epidermal growth factor receptor (EGFR) biology and Wnt developmental signaling highlight research endeavors of SCBA award winners.
    Jeang KT
    Cell Biosci; 2012 Apr; 2(1):12. PubMed ID: 22520574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload.
    Zou Y; Pan L; Shen Y; Wang X; Huang C; Wang H; Jin X; Yin C; Wang Y; Jia J; Qian J; Zou Y; Gong H; Ge J
    Cell Death Dis; 2021 Sep; 12(10):877. PubMed ID: 34564708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interaction of Wnt signaling members with growth factors in cultured granulosa cells.
    Tepekoy F; Akkoyunlu G
    Anim Reprod; 2020 Jun; 17(2):e20190106. PubMed ID: 32714449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic Correlates of Exceptional Response to ErbB3 Inhibition in Head and Neck Squamous Cell Carcinoma.
    Faden DL; Gomez-Casal R; Alvarado D; Duvvuri U
    JCO Precis Oncol; 2019; 3():. PubMed ID: 31440738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.